Zobrazeno 1 - 10
of 217
pro vyhledávání: '"Shaker R. Dakhil"'
Autor:
Jarrod P. Holmes, Shaker R. Dakhil, Vivek G Sunkari, Jason Lukas, Markus D. Lacher, William V. Williams, Elizabeth Tan-Chiu, Charles L. Wiseman, Carmen Calfa, George E. Peoples, Saveri Bhattacharya
Publikováno v:
Cancer Research. 81:PS17-20
Background: SV-BR-1-GM is a GM-CSF transfected breast cancer cell line, exceptional for having antigen-presenting capability and expressing both HLA I and II. The parent cell line, SV-BR-1, was derived from a patient with grade II (moderately differe
Autor:
Mario E. Lacouture, Michael J. Fisch, Justin D. Floyd, Gary V. Burton, Kathryn B. Arnold, Mario R. Velasco, Lynne I. Wagner, Heinz-Josef Lenz, Marianna Koczywas, Joseph M. Unger, James L. Wade, Afsaneh Barzi, N. Lynn Henry, Siu-Fun Wong, Dawn L. Hershman, Carol M. Moinpour, Benjamin Esparaz, Anna Moseley, Shaker R. Dakhil, Keisha C. Humphries
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 4, Iss 1, Pp 1-12 (2020)
Journal of Patient-Reported Outcomes
Journal of Patient-Reported Outcomes
Background Papulopustular rash is a common class effect of epidermal growth factor receptor inhibitors (EGFRI) that can affect patients’ health-related quality of life and cause disruptions to treatment. SWOG S1013 (NCT01416688) is a multi-center s
Autor:
Markus D. Lacher, Vivek G Sunkari, Shaker R. Dakhil, Charles L. Wiseman, Diane DaSilva, Saveri Bhattacharya, Carmen Calfa, Ajay Kundra, George E. Peoples, Jarrod P. Holmes, William V. Williams, Daniel L. Adams
Publikováno v:
Cancer Research. 80:P3-09
Background: SV-BR-1-GM is a GM-CSF transfected breast cancer cell line, exceptional for having antigen-presenting capability expressing both HLA I and II. We report clinical efficacy, safety, and immunologic correlates of response from our initial Ph
Autor:
Mark Clemons, Jieling L M'iao, Jeffrey S. Abrams, Daniel F. Hayes, Helen K. Chew, J. Margolis, Elizabeth Claire Dees, Kim Z Dammann, Gabriel N. Hortobagyi, William E. Barlow, Catherine Van Poznak, Anthony D. Elias, Mark M. Schubert, Carla I. Falkson, Robert B. Livingston, Danika L. Lew, Shaker R. Dakhil, James N. Ingle, Michael J. Messino, Alexander H.G. Paterson, Dawn L. Hershman, Julie R. Gralow, Alison Stopeck
Publikováno v:
J Natl Cancer Inst
Background Adjuvant bisphosphonates, when given in a low-estrogen environment, can decrease breast cancer recurrence and death. Treatment guidelines include recommendations for adjuvant bisphosphonates in postmenopausal patients. SWOG/Alliance/Canadi
Autor:
Wen Hong Lin, Carlos H. Barrios, Martin Reck, Ramaswamy Govindan, Neal Ready, Dimple Pandya, Hye Ryun Kim, Taofeek K. Owonikoko, Alejandro Navarro, Keunchil Park, Laurent Greillier, Ivor John Percent, Vanesa Gutierrez, Miten Patel, Jong Seok Lee, Parul Doshi, Michael Schenker, Solange Peters, Shaker R. Dakhil, Jerónimo Rodríguez-Cid, Daniel Morgensztern, Christine Baudelet, Sofia Baka, Jonathan F. Baden, Giovanni Selvaggi
Publikováno v:
Journal of clinical oncology, vol. 39, no. 12, pp. 1349-1359
Scientia
Journal of Clinical Oncology
Journal of Clinical Oncology, 2021, 39 (12), pp.1349-1359. ⟨10.1200/JCO.20.02212⟩
Scientia
Journal of Clinical Oncology
Journal of Clinical Oncology, 2021, 39 (12), pp.1349-1359. ⟨10.1200/JCO.20.02212⟩
PURPOSE In extensive-disease small-cell lung cancer (ED-SCLC), response rates to first-line platinum-based chemotherapy are robust, but responses lack durability. CheckMate 451, a double-blind phase III trial, evaluated nivolumab plus ipilimumab and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::362dcb13447f71920cccc0d1cd6b0b79
https://serval.unil.ch/resource/serval:BIB_78F0D04B7BA3.P001/REF.pdf
https://serval.unil.ch/resource/serval:BIB_78F0D04B7BA3.P001/REF.pdf
Autor:
Daniel J. George, Joel Picus, Olwen Hahn, Darren R. Feldman, Shaker R. Dakhil, Meghara K. Walsh, Susan Halabi, Colin Hessel, Michael J. Morris, Toni K. Choueiri, Christian Scheffold, M. Dror Michaelson, Eric J. Small, Milan Mangeshkar
Publikováno v:
The Oncologist
The phase II CABOSUN trial compared cabozantinib with sunitinib as initial treatment in patients with advanced renal cell carcinoma of intermediate or poor risk. This article presents subgroup analyses by baseline patient characteristics.
Caboza
Caboza
Autor:
W. Ken Zhen, Yolanda I. Garces, James L. Leenstra, Shaker R. Dakhil, Terence T. Sio, Apar Kishor Ganti, Daniel J. Ma, Jean-Claude M. Rwigema, Levi Pederson, Sonja J. van der Veen, Steven E. Schild, James D. Bearden, Pamela J. Atherton, Robert C. Miller, Robert W. Mutter
Publikováno v:
International Journal of Radiation Oncology Biology Physics, 103(3), 686-696. ELSEVIER SCIENCE INC
Purpose: Chemoradiation (CRT) is an integral treatment modality for patients with locally advanced lung cancer. It has been hypothesized that current use of an angiotensin-converting enzyme inhibitor during CRT may be protective for treatment-related
Autor:
Ann M. O'Mara, Victor Kipnis, Jerry W. Mitchell, Amber S. Kleckner, Charles S. Kamen, Luke J. Peppone, AnnaLynn M Williams, Jodi Geer, Carly Paterson Khan, Karen Mustian, Shaker R. Dakhil, Michelle C Janelsins, C. E. Heckler, Mary Ontko, Debra L. Barton
Publikováno v:
Breast Cancer Res Treat
PURPOSE: Fatigue and anxiety are common and significant symptoms reported by cancer patients. Few studies have examined the trajectory of multidimensional fatigue and anxiety, the relationships between them and with quality of life. METHODS: Breast c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71bc9e6aa63c81a412fdbb765c252c79
https://europepmc.org/articles/PMC8080260/
https://europepmc.org/articles/PMC8080260/
Autor:
Julie R. Gralow, Ming C. Kuan, Kathryn B. Arnold, Benjamin Esparaz, N. Lynn Henry, Anna Moseley, Douglas M. Lackowski, Alfred I. Neugut, Scott D. Ramsey, William Jeffery Edenfield, Zoneddy Dayao, GC Hillyer, Shaker R. Dakhil, Mark L. Graham, Joseph M. Unger, Dawn L. Hershman
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 38(19)
PURPOSE Nonadherence to aromatase inhibitors (AIs) for breast cancer is common and increases the risk of recurrence. Text messaging increases adherence to medications for chronic conditions. METHODS We conducted a randomized clinical trial of text me
Autor:
Charles L. Loprinzi, Teri Britt Pipe, Timothy J. Hobday, Rui Qin, Debra L. Barton, Kelli Fee-Schroeder, Shaker R. Dakhil, Daniel Satele, Pamela J. Atherton
Publikováno v:
Support Care Cancer
Sleep disturbance is a prevalent problem for cancer survivors and effective behavioral treatments are not widely used for this population. This study evaluated home-based sleep interventions based on cognitive behavioral therapy for insomnia (CBT-I).